X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Insights

Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation

Yuvraj_pawp by Yuvraj_pawp
31st July 2014
in Insights

Unique Pizza and Subs Corporation (“Unique,” OTC Markets Groups Inc.: OTC Pink: UPZS), a Delaware Corporation, is pleased to announce it has signed a distribution agreement with Larasan Pharmaceutical Corporation (“Larasan”), a nature-based pharmaceutical company that produces and distributes health-enhancing products.  According to the agreement, US-based Larasan will work with Unique to help distribute its health-oriented, gourmet 6″ frozen pizza through Larasan’s vast distribution network throughout China which includes several hundreds of thousands of retail points. Unique’s gourmet pizza utilizes natural cheeses, probiotics and enzymes that are deemed to be healthier than standard frozen pizzas, and appeals to the growing worldwide trend in health-conscious fast food.

The term of the agreement, signed by James C. Vowler President & CEO of Unique and by Sumair Mitroo, CEO of Larasan, covers the period April 22, 2014 through July 22, 2015, with the option of continuation.

Dr. M. S. Reddy, Senior Advisor of Unique Pizza and Subs Corporation, said, “We have been speaking with Sumair since the beginning of the year about his company’s immense distribution network and its ability to distribute our industry leading gourmet quality Uniquepizzas. This agreement is a big step towards getting our product to market and we look forward to working with Sumair and his team.  I have been working with the pizza industry for more than 40 years and I have contributed to the success and growth of many of the industry leaders. I have now found what I believe the pizza community has always needed a company that understands what quality really means. Jim has a passion and understanding of the pizza business like no one I have ever met and his drive for success without compromise in quality while maintaining integrity and loyalty is the reason I am on board.”

Larasan’s CEO, Sumair Mitroo, said, “Although Larasan is a pharmaceutical company with its own line of products that combine nature and bio-science to increase health, we will distribute other products that connect with this vision.  People around the world love pizza, and the demand is there for a gourmet and healthy pizza that can be served quickly.  After meeting the team at Unique Pizza, I was quickly convinced about their capabilities to fill this demand.  Jim is very driven and focused on improving his pizza business, and Dr. Reddy is already well known for his contributions in the pizza industry with his specialized cheese formulations.  Moreover, Dr. Reddy’s deep knowledge and expertise in probiotics will make significant impact on the success of this venture.  Our team is excited to work with Unique Pizza and distribute a truly unique pizza in China and Asia.”

About Larasan Pharmaceutical Corporation

Larasan is a nature-based pharmaceutical company with a broad range of transdermal (skin patch), oral, and liquid OTC products, for the prevention and/or treatment of pain, performance, bug bites, and energy.  Its products combine nature and bio-science through improved delivery systems to increase health.  Based in the US with operations in China, Larasan is an early stage pharmaceutical company with distribution in the US and Asia. For more information, visit www.larasan.com.

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward- looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions. There are no financials in this press release so this is not needed and undermines the release.

SOURCE Unique Pizza and Subs Corporation

Previous Post

Eisai and Arena Pharmaceuticals Announce BELVIQ(R) (lorcaserin HCl) CIV Nominated a Second Time for the Prix Galien Award in the Best Pharmaceutical Agent Category

Next Post

Meda agrees to acquire Rottapharm for €2.3bn

Related Posts

Regulatory Trends in Pharma
Insights

Regulatory Trends in Pharma Manufacturing to Watch in 2025

29th May 2025
Pharmaceutical-Chemicals Market Booms with Rising API Demand
Asia

Pharmaceutical Chemicals Market Booms with Rising API Demand

28th May 2025
Insights

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

27th May 2025
Capsules Market
Insights

Empty Capsules Market Growth to Reach $4.2B by 2029

16th April 2025
Omics Based Clinical Trials
Asia

Asia Pacific Omics-Based Clinical Trials Market Growth

16th April 2025
Insights

AstraZeneca Eyes Acquisition To Develop Cell Therapies

24th March 2025
Next Post

Pfizer to acquire Baxter’s portfolio of marketed vaccines for $635m

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In